mTOR acts as a regulator that controls cell metabolism, growth, and proliferation, and its inhibitor, rapamycin, has demonstrated efficacy in reducing inflammation and fibrosis, such as in non-alcoholic steatohepatitis[30]. The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatohepatitis.